Seattle, WA -- (SBWIRE) -- 09/25/2019 -- Global Stem Cell Assay Market, By Product Type (Instruments and Reagents & Kits), By Cell Type (Adult Stem Cells and Human Embryonic Stem Cells), By Process (Cell Culture, Engineering, Differentiation, Characterization, and Others), By Application (Research, Drug Discovery & Development, and Regenerative Medicine), and By Region - Global Industry Insights, Trends, Outlook, and Opportunity Analysis, 2019-2027

A stem cell is a cell that can develop specific types of cells in the body and also used to replace the damaged cells. Stem cells are classified into embryonic stem cells and adult stem cells. Stem cells are usually located in areas such as bone marrows, adipose tissue, and blood and they can be extracted from umbilical cord blood as well. The stem cell population in the body maintained via two processes namely stochastic differentiation and obligatory asymmetric replication and application of stem cells has shown a positive outcome in the treatment of various chronic disease such as cancer since stem cells play a very crucial role in the healing process of the body. Moreover, stem cells are broadly used for different processes such as isolation and purification of stem cells, cytotoxicity studying, cell identification, cell proliferation, and cell differentiation for research purposes. In the process of stem cell transplant, the embryonic cells are characterized into required adult cell type in the beginning. After which, these cells are utilized for restoring the damaged tissue caused by any disease or injury. NSC ICC Kit, stem Cell Pluripotency Array, TaqMan Array Mouse Stem Cell Pluripotency Panel, and TaqMan iPSC Sendai Detection Kit are some of the commercially available stem cells assays.

Request Sample Copy of Stem Cell Assay Market Research Report @ https://www.coherentmarketinsights.com/insight/request-sample/1632

Market Dynamic

Increasing cases of various chronic disease such as cancer and cardiovascular disease along with the ability of stem cell to manage the chronic disease are expected to drive the market growth stem cell assay during the forecast timeline. According to the American Cancer Society, in 2017, cancer was the second most common cause of death in the U.S., which accounted for nearly 1 out of every 4 deaths. Advanced treatment such as stem cell transplant is assumed to improve the medical result of chronic disease. Moreover, stem cell transplant is expected to replace the damaged neurons caused by stroke, spinal cord injury, and Alzheimer's disease, which in turn is anticipated to stimulate the market growth of stem cell assay. Besides, organizations such as California's Stem Cell Agency is engaged in the production of new stem cell-based therapies for chronic diseases such as cancer and rare diseases. For instance, key players such as Sangamo Therapeutics and Fate Therapeutics are working on stem cell-based therapies for diseases such as ?-Thalassemia and cancer respectively. The therapies are ST-400 Autologous HSPC Transplant and FT516: a natural killer cell immunotherapy respectively. Furthermore, owing to the significant increase in the stem cells researches and studies, the stem cell assay market is expected to witness significant growth over the forecast timeline. However, if stem cells are not properly differentiated into required adult cell type, the transplanted stem cell may turn to teratomas and there is a possibility of failure, which is expected to restrain the global stem cell assay market growth during the forecast period.

Market Insight

North America and Europe are projected to experience significant growth in the market over the forecast period, owing to the strong presence of players and researchers of stem cell-based therapies in the region. Moreover, North America market is expected to gain benefit over the forecast period on the account of presence of manufacturers such as ThermoFisher Scientific and Agilent Technologies, Inc. providing stem cell assay. At the same time, the Asia Pacific market is expected to exhibit significant growth as researchers from Japan and China are focusing on developing more stem cell-based therapies. For instance, in 2017, clinical trials of embryonic stem cells were introduced in China for Parkinson's disease.

Global Stem Cell Assay Market Competitive Landscape

Key players operating in the global stem cell assay market include Merck & Co., Thermo Fisher Scientific, GE Healthcare, Agilent Technologies, Bio-Rad Laboratories, Promega Corporation, Cell Biolabs, PerkinElmer, Miltenyi Biotec, HemoGenix, Bio-Techne Corporation, STEMCELL Technologies, and Cellular Dynamics International.

For More Details On Stem Cell Assay Market Report: https://www.coherentmarketinsights.com/ongoing-insight/stem-cell-assay-market-1632

Stem Cell Assay Market Taxonomy-

The global stem cell assay market is segmented on the basis of product type, cell type, process, application, and geography.

By Product Type-
- Instruments
- Reagents & Kits

By Cell Type –
- Adult Stem Cells
- Induced Pluripotent Stem Cells
- Mesenchymal Stem Cells
- Neural Stem Cells
- Hematopoietic Stem Cells
- Umbilical Cord Stem Cells
- Human Embryonic Stem Cells

By Process –
- Cell Culture
- Engineering
- Differentiation
- Characterization
- Others

By Application -
- Research
- Drug Discovery & Development
- Regenerative Medicine

By Region -
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa

Click Here To Buy Stem Cell Assay Market Exclusive Report @ https://www.coherentmarketinsights.com/insight/buy-now/1632

About Coherent Market Insights:
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.